Transition from the benign to malignant state also coincides with rise of genomic instability, which likely accelerates loss of function of key tumor suppressors (e.g. EED, SUZ12) and affects copy-number status of multiple oncogenes and other tumor suppressor genes. The gene discussed is EED; the disease is neoplasm.